The impact of novel treatment modalities on the therapeutic approach of cardiovascular diseases.
Paraskevas
Kosmas I
KI
Psathas
Chrisovalantis
C
Dragios
Theodoros
T
Chatzis
Dimitrios G
DG
Mikhailidis
Dimitri P
DP
Kyriakides
Zenon S
ZS
D043924:Angiogenesis Modulating Agents / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D017690:Cell Transplantation; D003131:Combined Modality Therapy; D003326:Coronary Circulation / Q000187:drug effects; D015316:Genetic Therapy; D006801:Humans; D018919:Neovascularization, Physiologic / Q000187:drug effects; D016896:Treatment Outcome
D043924:Angiogenesis Modulating Agents; D002317:Cardiovascular Agents